Smolej L - Search Results

1

Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index.

Sýkorová A, Procházka V, Móciková H, Janíková A, Pytlík R, Belada D, Benešová K, Klener P, Ďuraš J, Smolej L, Campr V, Blahovcová P, Trněný M. Sýkorová A, et al. Among authors: smolej l. Neoplasma. 2022 Dec;69(6):1466-1473. doi: 10.4149/neo_2022_221030N1064. Neoplasma. 2022. PMID: 36591807

2

Efficacy of pneumococcal vaccination in chronic lymphocytic leukemia: should we rely on surrogate markers?

Smolej L. Smolej L. Vaccine. 2008 Mar 10;26(11):1407. doi: 10.1016/j.vaccine.2008.01.010. Epub 2008 Jan 31. Vaccine. 2008. PMID: 18280013 No abstract available.

3

Quantitation of minimal residual disease in patients with chronic lymphocytic leukemia using locked nucleic acid-modified, fluorescently labeled hybridization probes and real-time PCR technology.

Peková S, Bezdícková L, Smolej L, Kozák T, Hochová I, Zák P, Tomsíková L, Průcha M. Peková S, et al. Among authors: smolej l. Mol Diagn Ther. 2007;11(5):325-35. doi: 10.1007/BF03256253. Mol Diagn Ther. 2007. PMID: 17963420

4

Identification of a novel, transactivation-defective splicing variant of p53 gene in patients with chronic lymphocytic leukemia.

Pekova S, Cmejla R, Smolej L, Kozak T, Spacek M, Prucha M. Pekova S, et al. Among authors: smolej l. Leuk Res. 2008 Mar;32(3):395-400. doi: 10.1016/j.leukres.2007.06.022. Epub 2007 Aug 3. Leuk Res. 2008. PMID: 17688945

5

[Angiogenesis in the bone marrow of patients with chronic lymphocytic leukaemia].

Kasparová P, Smolej L. Kasparová P, et al. Among authors: smolej l. Cesk Patol. 2007 Apr;43(2):50-8. Cesk Patol. 2007. PMID: 17623976 Czech.

6

[Apoptosis and angiogenesis in the chronic lymphocytic leukemia].

Smolej L. Smolej L. Cas Lek Cesk. 2004;143(7):499. Cas Lek Cesk. 2004. PMID: 15373297 Czech. No abstract available.

7

[The effect of polycyclic aromatic hydrocarbons to bone marrow].

Hrudková M, Fiala Z, Borská L, Novosad J, Smolej L. Hrudková M, et al. Among authors: smolej l. Acta Medica (Hradec Kralove) Suppl. 2004;47(2):75-81. Acta Medica (Hradec Kralove) Suppl. 2004. PMID: 16106736 Review. Czech.

8

[Therapeutic Options for "Slow go" Patients with Chronic Lymphocytic Leukemia].

Smolej L. Smolej L. Klin Onkol. 2015;28 Suppl 3:3S30-8. doi: 10.14735/amko20153s30. Klin Onkol. 2015. PMID: 26489499 Review. Czech.

9

[Angiogenesis and antiangiogenic cancer therapy].

Pour L, Hájek R, Buchler T, Maisnar V, Smolej L. Pour L, et al. Among authors: smolej l. Vnitr Lek. 2004 Dec;50(12):930-8. Vnitr Lek. 2004. PMID: 15717808 Review. Czech.

10

Why R-CHOP for first line treatment of chronic lymphocytic leukemia?

Smolej L. Smolej L. Int J Lab Hematol. 2007 Dec;29(6):478-9; author reply 479. doi: 10.1111/j.1365-2257.2006.00878_1.x. Int J Lab Hematol. 2007. PMID: 17988306 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page